A product's performance in a clinical trial doesn’t tell the full story. You need to understand how it works in the real world, with real patients. When you have access to real-world data organized in a clinical registry, you can generate real-world evidence that can be used for post-market surveillance to:
You need an efficient and secure way to collect large amounts of real-world data and prepare it for analysis. With the right technology, you can collect data from medical records, regulatory sources, patient-reported outcomes, and more for post-market surveillance activities.
It takes more than raw data alone to achieve your post-market surveillance goals. Once you collect your data, you need to aggregate, validate, and analyze those various data sources to produce reliable real-world evidence.
With real-world evidence at your fingertips, you can quickly measure clinical outcomes, determine patient quality of life, and understand financial impacts. Our solutions help you make informed decisions and fulfill post-market surveillance requirements.
Our analytics solutions provide you with precise answers that empower evidence-based action. We transform data into useful insights and give you real-time access so you can:
"Clinicians, industry, and regulators value real-world data and evidence to improve product development, develop new indications, and promote patient safety. The ELSO Evidence Explorer from ArborMetrix provides a novel platform to rapidly and easily explore the real-world data from the largest collection of multi-national ECMO centers in the world."
Post-market surveillance demonstrates the real-world safety and effectiveness of medical devices and pharmaceuticals by collecting, analyzing, and interpreting product or treatment data. It is an active, ongoing process that should provide up-to-date insights that can be used to make adjustments and improvements.
Pharmaceutical and medical device companies rely on the real-world insights they gain through post-market surveillance activities to:
Clinical data registries that collect real-world data, transform it into real-world evidence, and make it accessible are uniquely useful in their ability to facilitate post-market surveillance. They help organizations better understand the real-world safety and effectiveness of their procedures, treatments, and devices so they can make informed decisions moving forward.
Learn more about how post-market surveillance can help your organization.
Leverage high-quality, research-grade evidence to accelerate clinical research, and encourage deeper investigation into trends and outcomes.
Advance care, reduce adverse events, and improve guideline adherence with credible, evidence-based insights that drive measurable improvement.